Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: A study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene

Heart

Volumn 87, Issue 3, 2002, Pages 270-275

  Ortlepp, J R ^a   Vosberg, H P ^b   Reith, S ^a   Ohme, F ^a   Mahon, N G ^c   Schroder D ^b   Klues, H G ^a   Hanrath, P ^a   McKenna, W J ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CHYMASE; MYOSIN BINDING PROTEIN C; RENIN;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HETEROZYGOTE; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MALE; MULTIVARIATE ANALYSIS; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SEX DIFFERENCE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0036178004     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.3.270     Document Type: Article

References (37)

1. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
2. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
3. The management of hypertrophic cardiomyopathy
4. Molecular biology of the renin-angiotensin system
5. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype
6. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
7. Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
8. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation
9. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
10. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy
11. Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
12. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy
13. AT1 receptor A/C1 166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy
14. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function
15. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy
16. Molecular basis of human hypertension: Role of angiotensinogen
17. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
18. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction
19. Is the A1 166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease?
20. Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration
21. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels
22. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance
23. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
24. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two dimensional echocardiographic study of 125 patients
25. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
26. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families
27. The quest for optimal electrocardiography. Task Force I: Standardization of terminolagy and interpretation
28. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension
29. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
30. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training
31. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis
32. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure
33. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass
34. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries
35. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes
36. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart
37. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo